| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
PEYE Stock Overview
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area.
Precision Optics Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.90 |
| 52 Week High | US$3.00 |
| 52 Week Low | US$1.52 |
| Beta | 0.47 |
| 1 Month Change | -5.00% |
| 3 Month Change | -7.77% |
| 1 Year Change | 10.47% |
| 3 Year Change | 27.52% |
| 5 Year Change | 322.22% |
| Change since IPO | -99.73% |
Recent News & Updates
Shareholder Returns
| PEYE | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -4.0% | -3.5% | -3.3% |
| 1Y | 10.5% | -14.0% | -8.1% |
Return vs Industry: PEYE exceeded the US Medical Equipment industry which returned -11.5% over the past year.
Return vs Market: PEYE exceeded the US Market which returned -4.3% over the past year.
Price Volatility
| PEYE volatility | |
|---|---|
| PEYE Average Weekly Movement | 7.6% |
| Medical Equipment Industry Average Movement | 9.3% |
| Market Average Movement | 7.5% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: PEYE is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.
Volatility Over Time: PEYE's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1982 | 51 | Joe Forkey | https://www.poci.com |
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies, which are designed for industrial and military use.
Precision Optics Corporation Fundamentals Summary
| PEYE fundamental statistics | |
|---|---|
| Market Cap | US$32.14m |
| Earnings (TTM) | -US$973.99k |
| Revenue (TTM) | US$11.36m |
2.8x
P/S Ratio-33.0x
P/E RatioIs PEYE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PEYE income statement (TTM) | |
|---|---|
| Revenue | US$11.36m |
| Cost of Revenue | US$8.00m |
| Gross Profit | US$3.36m |
| Other Expenses | US$4.34m |
| Earnings | -US$973.99k |
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.058 |
| Gross Margin | 29.59% |
| Net Profit Margin | -8.57% |
| Debt/Equity Ratio | 27.3% |
How did PEYE perform over the long term?
See historical performance and comparisonValuation
Is Precision Optics Corporation undervalued compared to its fair value and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PEG Ratio
PB vs Industry
3.5x
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate PEYE's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate PEYE's fair value for valuation analysis.
Price To Earnings Ratio
PE vs Industry: PEYE is unprofitable, so we can't compare its PE Ratio to the US Medical Equipment industry average.
PE vs Market: PEYE is unprofitable, so we can't compare its PE Ratio to the US market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate PEYE's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: PEYE is overvalued based on its PB Ratio (3.5x) compared to the US Medical Equipment industry average (2.7x).
Future Growth
How is Precision Optics Corporation forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score
0/6Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Future ROE
16.5%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Precision Optics Corporation has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Past Performance
How has Precision Optics Corporation performed over the past 5 years?
Past Performance Score
0/6Past Performance Score 0/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
1.2%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PEYE is currently unprofitable.
Growing Profit Margin: PEYE is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: PEYE is unprofitable, but has reduced losses over the past 5 years at a rate of 1.2% per year.
Accelerating Growth: Unable to compare PEYE's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: PEYE is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (23%).
Return on Equity
High ROE: PEYE has a negative Return on Equity (-10.6%), as it is currently unprofitable.
Financial Health
How is Precision Optics Corporation's financial position?
Financial Health Score
5/6Financial Health Score 5/6
Short Term Liabilities
Long Term Liabilities
Debt Level
Reducing Debt
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: PEYE's short term assets ($6.4M) exceed its short term liabilities ($4.6M).
Long Term Liabilities: PEYE's short term assets ($6.4M) exceed its long term liabilities ($3.1M).
Debt to Equity History and Analysis
Debt Level: PEYE's net debt to equity ratio (13.6%) is considered satisfactory.
Reducing Debt: PEYE's debt to equity ratio has increased from 0% to 27.3% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PEYE has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: PEYE has sufficient cash runway for 1.8 years if free cash flow continues to grow at historical rates of 5.1% each year.
Dividend
What is Precision Optics Corporation current dividend yield, its reliability and sustainability?
Dividend Score
0/6Dividend Score 0/6
Notable Dividend
High Dividend
Stable Dividend
Growing Dividend
Earnings Coverage
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate PEYE's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate PEYE's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if PEYE's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if PEYE's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as PEYE has not reported any payouts.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
2.9yrs
Average management tenure
CEO
Joe Forkey (53 yo)
11.25yrs
Tenure
US$440,909
Compensation
Dr. Joseph N. Forkey, also known as Joe, has been Chief Executive Officer, President and Treasurer of Precision Optics Corp., Inc., since February 8, 2011. Dr. Forkey has been a Director at Precision Optic...
CEO Compensation Analysis
Compensation vs Market: Joe's total compensation ($USD440.91K) is below average for companies of similar size in the US market ($USD726.26K).
Compensation vs Earnings: Joe's compensation has increased whilst the company is unprofitable.
Leadership Team
Experienced Management: PEYE's management team is considered experienced (2.9 years average tenure).
Board Members
Experienced Board: PEYE's board of directors are considered experienced (9.5 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 28.2%.
Top Shareholders
Company Information
Precision Optics Corporation, Inc.'s employee growth, exchange listings and data sources
Key Information
- Name: Precision Optics Corporation, Inc.
- Ticker: PEYE
- Exchange: OTCPK
- Founded: 1982
- Industry: Health Care Equipment
- Sector: Healthcare
- Implied Market Cap: US$32.139m
- Shares outstanding: 16.92m
- Website: https://www.poci.com
Number of Employees
Location
- Precision Optics Corporation, Inc.
- 22 East Broadway
- Gardner
- Massachusetts
- 1440
- United States
Listings
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2022/05/05 00:00 |
| End of Day Share Price | 2022/05/05 00:00 |
| Earnings | 2021/12/31 |
| Annual Earnings | 2021/06/30 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.